Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 62 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 9211419

    Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy

    The Board of Regents of the University of Texas System · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  2. US 9200015

    Inositol hexakisphosphate analogs and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  3. US 9198950

    Recombinant bacterium comprising a toxin/antitoxin system

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  4. US 9200024

    Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases

    The Board of Regents of the University of Oklahoma · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  5. US 9198915

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  6. US 9192578

    Hot-melt extrusion of modified release multi-particulates

    The Board of Regents of the University of Texas System · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  7. US 9187523

    Substrate peptide sequences for plague plasminogen activator and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  8. US 9186400

    Compositions for stimulation of mammalian innate immune resistance to pathogens

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  9. US 9186362

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  10. US 9180102

    Methods for fabricating nano and microparticles for drug delivery

    The Board of Regents of the University of Texas System · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  11. US 9175041

    Crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline, and methods for preparing dolamethylleuine and dolaphenvaline

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  12. US 9175058

    Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases

    The Board of Regents of the University of Texas System · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  13. US 9173839

    Anionic lipids and lipid nano-structures and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  14. US 9175906

    Drug particles from freezing onto a surface

    The Board of Regents of the University of Texas System · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  15. US 9174917

    Bexarotene analogs

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  16. US 9173975

    Reparative cell delivery via hyaluronic acid vehicles

    The Board of Regents of the University of Texas System · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  17. US 9173862

    Methods and compositions for treating and identifying compounds to treat age-related macular degeneration

    Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  18. US 9169509

    Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity

    The Board of Regents of the University of Texas System · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  19. US 9162980

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  20. US 9161969

    Protection against influenza infection by granulocyte-macrophage colony stimulating factor

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  21. US 9163085

    Anti-OX40 antibodies and methods of treating cancer

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  22. US 9155703

    Method and process for the production of multi-coated recognitive and releasing systems

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  23. US 9157916

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  24. US 9156787

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.